Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Moschini

Showing results (231-240 of 561) with videos related to

Pageof 57
Sort By:
European Urology Focus|June 13, 2026
First-line Therapy for Metastatic Renal Cell Carcinoma: An Updated Network Meta-analysis using Final Follow-up DataTakafumi Yanagisawa, Keiichiro Mori, Wataru Fukuokaya, et al.
Expert Review of Anticancer Therapy|August 31, 2019
Therapeutic approaches for lymph node involvement in prostate, bladder and kidney cancerArmando Stabile, Fabio Muttin, Stefania Zamboni, et al.
European Urology Focus|July 30, 2017
Survival Outcomes in Octogenarian and Nonagenarian Patients Treated with First-line Androgen Deprivation Therapy for Organ-confined Prostate CancerPaolo Dell'Oglio, Mohamed Bishr, Katharina Boehm, et al.
Clinical Genitourinary Cancer|January 2, 2017
Pure but Not Mixed Histologic Variants Are Associated With Poor Survival at Radical Cystectomy in Bladder Cancer PatientsMarco Moschini, Shahrokh F Shariat, Roberta Lucianò, et al.
Bladder Cancer (Amsterdam, Netherlands)|April 29, 2025
Advancements in systemic therapy for muscle-invasive bladder cancer: A systematic review from the beginning to the latest updatesTakafumi Yanagisawa, Akihiro Matsukawa, Jeremy Yuen-Chun Teoh, et al.
Clinical Genitourinary Cancer|September 4, 2016
Effect of Stage Migration on Bladder Cancer: A Slow but Steady Improvement in Long-Term Survival Rates After Radical Cystectomy in Previous 25 YearsMarco Moschini, Stefano Luzzago, Walter Cazzaniga, et al.
The Journal of Urology|April 23, 2019
Association between Inflammatory Potential of Diet and Bladder Cancer Risk: Results of 3 United States Prospective Cohort StudiesMohammad Abufaraj, Fred K Tabung, Shahrokh F Shariat, et al.
Clinical Genitourinary Cancer|August 26, 2020
Accuracy of MRI-guided Versus Systematic Prostate Biopsy in Patients Under Active Surveillance: A Systematic Review and Meta-analysisWilly Baccaglini, Felipe A Glina, Cristiano Linck Pazeto, et al.
European Urology|September 12, 2024
Tissue-based Biomarkers Steering Clinical Decisions in Patients with Urothelial CancerLuca Afferi, Alessia Cimadamore, Andrea Gallioli, et al.
European Journal of Cancer (Oxford, England : 1990)|May 7, 2021
First-line immune-checkpoint inhibitor combination therapy for chemotherapy-eligible patients with metastatic urothelial carcinoma: A systematic review and meta-analysisKeiichiro Mori, Benjamin Pradere, Marco Moschini, et al.
Pageof 57

Showing results (231-240 of 561) with videos related to

Sort By:
Pageof 57
European Urology Focus|June 13, 2026
First-line Therapy for Metastatic Renal Cell Carcinoma: An Updated Network Meta-analysis using Final Follow-up DataTakafumi Yanagisawa, Keiichiro Mori, Wataru Fukuokaya, et al.
Expert Review of Anticancer Therapy|August 31, 2019
Therapeutic approaches for lymph node involvement in prostate, bladder and kidney cancerArmando Stabile, Fabio Muttin, Stefania Zamboni, et al.
European Urology Focus|July 30, 2017
Survival Outcomes in Octogenarian and Nonagenarian Patients Treated with First-line Androgen Deprivation Therapy for Organ-confined Prostate CancerPaolo Dell'Oglio, Mohamed Bishr, Katharina Boehm, et al.
Clinical Genitourinary Cancer|January 2, 2017
Pure but Not Mixed Histologic Variants Are Associated With Poor Survival at Radical Cystectomy in Bladder Cancer PatientsMarco Moschini, Shahrokh F Shariat, Roberta Lucianò, et al.
Bladder Cancer (Amsterdam, Netherlands)|April 29, 2025
Advancements in systemic therapy for muscle-invasive bladder cancer: A systematic review from the beginning to the latest updatesTakafumi Yanagisawa, Akihiro Matsukawa, Jeremy Yuen-Chun Teoh, et al.
Clinical Genitourinary Cancer|September 4, 2016
Effect of Stage Migration on Bladder Cancer: A Slow but Steady Improvement in Long-Term Survival Rates After Radical Cystectomy in Previous 25 YearsMarco Moschini, Stefano Luzzago, Walter Cazzaniga, et al.
The Journal of Urology|April 23, 2019
Association between Inflammatory Potential of Diet and Bladder Cancer Risk: Results of 3 United States Prospective Cohort StudiesMohammad Abufaraj, Fred K Tabung, Shahrokh F Shariat, et al.
Clinical Genitourinary Cancer|August 26, 2020
Accuracy of MRI-guided Versus Systematic Prostate Biopsy in Patients Under Active Surveillance: A Systematic Review and Meta-analysisWilly Baccaglini, Felipe A Glina, Cristiano Linck Pazeto, et al.
European Urology|September 12, 2024
Tissue-based Biomarkers Steering Clinical Decisions in Patients with Urothelial CancerLuca Afferi, Alessia Cimadamore, Andrea Gallioli, et al.
European Journal of Cancer (Oxford, England : 1990)|May 7, 2021
First-line immune-checkpoint inhibitor combination therapy for chemotherapy-eligible patients with metastatic urothelial carcinoma: A systematic review and meta-analysisKeiichiro Mori, Benjamin Pradere, Marco Moschini, et al.
Pageof 57